Enhancing Screening Practices for BE

Part of paid clinical trials in New Brunswick, New Jersey.

Sponsor
Rutgers, The State University of New Jersey
Study ID
NCT07335445
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Barrett's Esophagus

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Screening Reminder — OTHER
    A reminder to screen this patient for Barrett's esophagus (BE) will be sent to the provider before the patient's scheduled appointment. The reminder will provide details about which criteria this patient meets in order to indicate that BE screening should be initiated.

Study Details

Previous studies have shown that screening for Barrett's esophagus (BE), the main risk factor for esophageal adenocarcinoma, is under-utilized in the primary care setting. In fact less than 35% of eligible patients are screened despite endorsement for screening by the major GI societies in patients with risk factors. The purpose of this study is to examine current screening practices and determine if implementation of screening reminders can optimize screening practices for Barrett's Esophagus within a large, academic based healthcare system in NJ.

Key Dates

Start date
May 31, 2026
Status verified
Jan 2026
Primary completion
Dec 31, 2028
Completion
Jun 30, 2029

Study Design

Enrollment
3,000 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING

Arms

  • No Intervention: Standard of Care
  • Active Comparator: Intervention

Primary Outcome Measure

BE screening rate [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Robert Wood Johnson Medical SchoolNew BrunswickNew Jersey08901
Molly Stewart
[email protected]
732-235-3247
Arvind Trindade, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New Brunswick, NJ

By research site
Robert Wood Johnson Medical School· New Brunswick, NJ

Related Studies